Brent L. Saunders
CIK: 0001268854
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Aug 5, 2026BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct4.2K shares at avg. $16.76$71K - Aug 5, 2026BLCO
Bausch & Lomb Corp
Award(A)Direct281.9K shares- - Jun 24, 2026SPRY
ARS Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
30K shares- - May 22, 2026BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct2.9K shares at avg. $15.92$46K - Mar 6, 2026BLCO
Bausch & Lomb Corp
Purchase(P)Direct14.7K shares at avg. $17.14$252K - Mar 6, 2026BLCO
Bausch & Lomb Corp
Award(A)Direct14.7K shares- - Feb 27, 2026BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct24.6K shares at avg. $18.30$451K - Feb 26, 2026BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct22.1K shares at avg. $18.49$408K - Feb 25, 2026BLCO
Bausch & Lomb Corp
Award(A)Direct327.1K shares- - Feb 23, 2026BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct65.4K shares at avg. $17.99$1.2M - Aug 5, 2025BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct4.2K shares at avg. $14.44$61K - Jul 21, 2025BLCO
Bausch & Lomb Corp
Award(A)DirectPerformance Stock Units
150K shares- - Jun 25, 2025SPRY
ARS Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
30K shares- - Jun 16, 2025SKIN
Beauty Health Co
Award(A)Direct73.1K shares- - May 22, 2025BLCO
Bausch & Lomb Corp
Award(A)Direct22K shares- - May 22, 2025BLCO
Bausch & Lomb Corp
Purchase(P)Direct22K shares at avg. $11.28$248K - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
Sale(S)Direct120K shares at avg. $14.25$1.7M - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
Exercise(M)Direct120K shares at avg. $1.01$121K - Feb 26, 2025BLCO
Bausch & Lomb Corp
Award(A)Direct168.2K shares- - Dec 23, 2024BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct24.6K shares at avg. $17.83$439K - Dec 23, 2024BLCO
Bausch & Lomb Corp
Tax Payment(F)Direct73.8K shares at avg. $17.83$1.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 5, 2026 |  BLCO Bausch & Lomb Corp | Tax Payment(F) | 4,231 | $16.76 | $70,912 | Direct |
| Aug 5, 2026 | BLCO Bausch & Lomb Corp | Award(A) | 281,879 | - | $0 | Direct |
| Jun 24, 2026 |  SPRY ARS Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 22, 2026 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 2,886 | $15.92 | $45,945 | Direct |
| Mar 6, 2026 | BLCO Bausch & Lomb Corp | Purchase(P) | 14,700 | $17.14 | $251,958 | Direct |
| Mar 6, 2026 | BLCO Bausch & Lomb Corp | Award(A) | 14,700 | - | $0 | Direct |
| Feb 27, 2026 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 24,649 | $18.30 | $451,077 | Direct |
| Feb 26, 2026 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 22,059 | $18.49 | $407,871 | Direct |
| Feb 25, 2026 | BLCO Bausch & Lomb Corp | Award(A) | 327,102 | - | $0 | Direct |
| Feb 23, 2026 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 65,444 | $17.99 | $1,177,338 | Direct |
| Aug 5, 2025 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 4,231 | $14.44 | $61,096 | Direct |
| Jul 21, 2025 | BLCO Bausch & Lomb Corp | Award(A) Performance Stock Units | 150,000 | - | - | Direct |
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jun 16, 2025 |  SKIN Beauty Health Co | Award(A) | 73,051 | - | - | Direct |
| May 22, 2025 | BLCO Bausch & Lomb Corp | Award(A) | 22,000 | - | - | Direct |
| May 22, 2025 | BLCO Bausch & Lomb Corp | Purchase(P) | 22,000 | $11.28 | $248,072 | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale(S) | 120,000 | $14.25 | $1,710,024 | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise(M) | 120,000 | $1.01 | $121,200 | Direct |
| Feb 26, 2025 | BLCO Bausch & Lomb Corp | Award(A) | 168,168 | - | - | Direct |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 24,649 | $17.83 | $439,492 | Direct |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | Tax Payment(F) | 73,782 | $17.83 | $1,315,533 | Direct |
1-21 of 21 transactions
About SAUNDERS BRENT L
SAUNDERS BRENT L (SEC CIK 0001268854) files insider reports with the SEC as Chairman of the Board and CEO of Bausch & Lomb Corp (BLCO), Director of ARS Pharmaceuticals, Inc. (SPRY) and Director of Beauty Health Co (SKIN).
Signal8 holds 15 ownership filings by SAUNDERS BRENT L, all Form 4s, filed between Dec 26, 2024 and Aug 7, 2026. Those filings report 21 transactions, from Dec 23, 2024 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SAUNDERS BRENT L's filings is in VAUGHAN.
Recent filings by SAUNDERS BRENT L
- Aug 5, 2026: Tax withholding of BLCO shares (Form 4, code F).
- Aug 5, 2026: Grant or award of BLCO shares (Form 4, code A).
- Jun 24, 2026: Grant or award of SPRY derivative securities (Form 4, code A).
- May 22, 2026: Tax withholding of BLCO shares (Form 4, code F).
- Mar 6, 2026: Open-market purchase of BLCO shares (Form 4, code P).
Other insiders filing for Bausch & Lomb Corp (BLCO)
- Munsch Frederick, SVP, Controller and CAO
- ROBERTSON RUSSEL C, Director
- Paulson John, Director
- Alfonso Eduardo, Director
- Trebbi Barbara, Director
- PAUL LAURENCE E, Director